Compass Therapeutics LLC

New Filing
CIK: 0001610824·Biotechnology·DELAWARE·Filed: Jul 1, 2015
Total Offering

$120,977,535

Amount Sold

$15,977,535

Investors

11

First Sale

Jun 17, 2015

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Errik Anderson
Related Person
Thomas Schuetz
Related Person
Steve Tregay
Related Person
Ben Auspitz
Related Person
Philip Ferneau
Related Person
Carl Gordon
Related Person
Stephen Squinto
Related Person

Company

Compass Therapeutics LLC

44 SOUTH MAIN STREET

HANOVER, NH, 03755

617-500-8099

SEC Filing

0001610824-15-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Compass Therapeutics LLC Form D Filing — $120,977,535 | FilingFlow